Japan Flow Cytometry Market Size & Outlook, 2023-2030
Japan flow cytometry market, 2018-2030 (US$M)
Related Markets
Japan flow cytometry market highlights
- The Japan flow cytometry market generated a revenue of USD 217.7 million in 2023 and is expected to reach USD 358.6 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 217.7 million |
| Market revenue in 2030 | USD 358.6 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Japan accounted for 5.0% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 590.5 million by 2030.
Instruments was the largest segment with a revenue share of 36.15% in 2023. Horizon Databook has segmented the Japan flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is anticipated to account for a significant share of Asia Pacific flow cytometry market, as it has one of the most developed pharmaceutical and biotechnology sectors in the region. Moreover, high prevalence of chronic diseases and COVID-19 pandemic has led to increase in R&D activities for the development of novel therapies and vaccines, thus creating high demand for flow cytometry solutions for research purposes.
Furthermore, increasing penetration of key players in Japan market is anticipated to support the regional growth. For instance, in November 2019, Cytek Biosciences, a U.S.-based manufacturer and supplier of flow cytometry, established its office in Tokyo, Japan to better engage with and support customers. Moreover, presence of local players including Sysmex Corporation has facilitated access to flow cytometry products in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan flow cytometry market size, by product, 2018-2030 (US$M)
Japan Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
